| 前收市價 | 227.59 |
| 開市 | 230.00 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 227.46 - 232.55 |
| 52 週波幅 | 154.10 - 232.55 |
| 成交量 | |
| 平均成交量 | 7,518 |
| 市值 | 660.998M |
| Beta 值 (5 年，每月) | 1.10 |
| 市盈率 (最近 12 個月) | 0.61 |
| 每股盈利 (最近 12 個月) | 3.84 |
| 業績公佈日 | 2024年7月30日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksQuest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
ZacksGE HealthCare (GEHC) Unveils Head-Only MR Scanner SIGNA MAGNUS
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
ZacksAvanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
